NCT05390671View on ClinicalTrials.gov

CAR-T Cell Therapy in Patients With Hematological Malignancies

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

June 1, 2021

Conditions
CART Therapy
Trial Locations (1)

Unknown

Angel Cedillo, Madrid

All Listed Sponsors
lead

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

OTHER

NCT05390671 - CAR-T Cell Therapy in Patients With Hematological Malignancies | Biotech Hunter | Biotech Hunter